As a new Congress begins, the mental health and broader disability community is losing a champion with the retirement of Rep. Rodney Frelinghuysen (R-N.J.). Since taking office in 1995, Frelinghuysen ...

A new study co-authored by MaryAnn Demchak, Ph.D., professor of special education at the University of Nevada, Reno, and Brianna Grumstrup, Ph.D., assistant professor of special education at the ...

Gov. Kim Reynolds sent shock waves through the disability community with her recent announcement that she is closing the Glenwood State Resource Center, home to about 200 Iowans with a variety of ...

Scholar argues that courts should adopt a systemic violation exception to IDEA’s exhaustion requirement.

In a new study commissioned by the Ruderman Family Foundation, it was revealed that 22% of all characters with disabilities on network television and 20% of such characters on streaming services are ...

An ABLE account is a savings account for people with disabilities. ABLE programs are established by states, and there are ...

ORLANDO, Fla.— Children with disabilities in foster care are extremely vulnerable, facing risks of maltreatment and removal from their homes and greater need for healthcare services. New research ...

More than sixty-one million Americans have disabilities, and increasing evidence documents that they experience health care disparities. Although many factors likely contribute to these disparities, ...

This month marks 34 years since the Americans with Disabilities Act was signed into law, and Disability Pride Month was officially established nearly a decade ago. As one blind author and illustrator ...

A crowd of over 150 Alaskans from across the state gathered on the steps of the Alaska State Capitol on Wednesday to rally and advocate for people with disabilities, their families and support ...

The U.S. Education Department announced Thursday that it is discharging the outstanding student loans of more than 323,000 borrowers who have significant, permanent disabilities, and will remove ...

"Alemtuzumab is the first disease modifying therapy to show a significant effect both on relapse and disability endpoints over and above those of Rebif in a comparative trial," said Professor Alastair ...